<SEC-DOCUMENT>0001144204-19-031965.txt : 20190621
<SEC-HEADER>0001144204-19-031965.hdr.sgml : 20190621
<ACCEPTANCE-DATETIME>20190621201608
ACCESSION NUMBER:		0001144204-19-031965
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190621
FILED AS OF DATE:		20190621
DATE AS OF CHANGE:		20190621

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adynxx, Inc.
		CENTRAL INDEX KEY:			0001054274
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-56066
		FILM NUMBER:		19913062

	BUSINESS ADDRESS:	
		STREET 1:		100 PINE ST., STE. 500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111
		BUSINESS PHONE:		(415) 512-7740

	MAIL ADDRESS:	
		STREET 1:		100 PINE ST., STE. 500
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94111

	FORMER NAME:	
		FORMER CONFORMED NAME:	Alliqua BioMedical, Inc.
		DATE OF NAME CHANGE:	20140610

	FORMER NAME:	
		FORMER CONFORMED NAME:	Alliqua, Inc.
		DATE OF NAME CHANGE:	20101222

	FORMER NAME:	
		FORMER CONFORMED NAME:	HEPALIFE TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20030529

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AquaMed Technologies, Inc.
		CENTRAL INDEX KEY:			0001468929
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				264042544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		850 THIRD AVENUE
		STREET 2:		SUITE 1801
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		646-218-1405

	MAIL ADDRESS:	
		STREET 1:		850 THIRD AVENUE
		STREET 2:		SUITE 1801
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tv524027_form3.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2019-06-21</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001468929</issuerCik>
        <issuerName>AquaMed Technologies, Inc.</issuerName>
        <issuerTradingSymbol>NONE</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001054274</rptOwnerCik>
            <rptOwnerName>Adynxx, Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 PINE STREET, SUITE 500</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN FRANCISCO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94111</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>5005211</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <remarks>This Form 3 is being filed by Adynxx, Inc. (formerly Alliqua BioMedical, Inc.) (the &quot;Company&quot;) in connection with the registration of the common stock of AquaMed Technologies, Inc. (&quot;AquaMed&quot;) with the Securities and Exchange Commission (the &quot;SEC&quot;) under Section 12(g) of the Securities Exchange Act of 1934, as amended, pursuant to a Registration Statement on Form 10 filed by AquaMed and declared effective by the SEC. AquaMed is currently a direct wholly-owned subsidiary of the Company. On June 21, 2019, in connection with the registration of AquaMed common stock with the SEC, the Company will effect its previously announced distribution of all of the outstanding shares of common stock of AquaMed.</remarks>

    <ownerSignature>
        <signatureName>/s/ Rick Orr, President and Chief Executive Officer</signatureName>
        <signatureDate>2019-06-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
